Meanwhile, dual agonists, which target and activate both the GLP-1 (Glucagon-like peptide-1) receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor, and triple agonists (targeting the GLP-1+GIP+Glucagon receptors) are also showing promise
These medicines work on brain reward pathways and satiety signals, potentially reducing food cravings and binge episodes
Full results from IV drip skin treatment depend on consistency and lifestyle
10.1096/fj.201600646R Summary Keywords cannabinoids, Cannabis sativa, inverse molecular docking, inverse molecular docking fingerprints, mode of action, virtual screening, drug design Citation Ravnik V, Juki M, Furlan V, Maver U, Roanc J and Bren U (2025) Uncovering the molecular targets of phytocannabinoids: mechanistic insights from inverse molecular docking fingerprint approaches